US regulatory status: approved. Mechanism: Unknown.
- Mechanism
- Unknown
pharma · EBV-induced Lymphomas · Coronary Artery Disease
Evidence Based Cataract
Evidence Based Cataract Study Group
Evidence Based Cataract drug portfolio — 8 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
THOUSAND OAKS, CA, CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- THOUSAND OAKS, CA, CN
- Programs
- 10
- Drugs
- 8
- Patents
- 10
Evidence Based Cataract pipeline
Portfolio lens on 8 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Evidence Based Cataract drug portfolio — 8 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to Evidence Based Cataract in public FDA and regional records.
-
clopidogrel
Blood and blood forming organs (B01)Blood and blood forming organs (B01) compound in Evidence Based Cataract's portfolio. Mechanism: Purinergic receptor P2Y12 antagonist.
- Mechanism
- Purinergic receptor P2Y12 antagonist
-
US regulatory status: approved. Molecular target: DNA.
- Target
- DNA
- Mechanism
- DNA inhibitor
-
US regulatory status: approved. Molecular target: Peroxisome proliferator-activated receptor alpha.
- Target
- Peroxisome proliferator-activated receptor alpha
- Mechanism
- Peroxisome proliferator-activated receptor alpha agonist
-
Development asset linked to Evidence Based Cataract in public FDA and regional records.
-
Development asset linked to Evidence Based Cataract in public FDA and regional records.
-
Development asset linked to Evidence Based Cataract in public FDA and regional records. Mechanism: The T-cell receptor recognises an EBV peptide in complex with a specific HLA molecule on the surface of target cells to exert cytotoxic activity.
- Mechanism
- The T-cell receptor recognises an EBV peptide in complex with a specific HLA molecule on the surface of target cells to exert cytotoxic activity